Market closed
Access this stock data via API
Subscribe
Eql Pharma AB
0
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 373.5M 264.2M 259.9M 409.8M
Cost of revenue 217.6M 149.1M 144.1M 314.0M
Gross profit 156.0M 115.0M 115.9M 95.7M
Operating expense
Research & development 11.3M 12.1M 15.1M 9.1M
Selling general and admin 78.5M 70.8M 59.8M 48.2M
Other operating expenses
Operating income 66.4M 32.2M 41.1M 38.6M
Non operating interest income
Income 7K 195K 1K 0
Expense 12.3M 5.7M 2.4M 2.9M
Other income expense
Pretax income 54.4M 28.6M 39.0M 36.0M
Tax provision 11.2M 5.9M 8.0M 4.4M
Net income 43.1M 22.7M 30.9M 31.5M
Basic EPS 1.5 0.8 1.1 1.1
Diluted EPS 1.4 0.8 1.0 1.1
Basic average shares 29.1M 29.1M 29.1M 29.1M
Diluted average shares 29.1M 29.1M 29.1M 29.1M
EBITDA 79.3M 41.6M 41.3M 49.1M
Net income from continuing op. 67.4M 32.6M 41.3M 36.0M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 38 minutes

08:21
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).